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A B S T R A C T
Objective: To evaluate a group-based self-management program (SMP) delivered as part of a quality
improvement program, Co-Creating Health, for patients living with one of four long-term conditions
(LTCs): chronic obstructive pulmonary disease, depression, diabetes, and musculoskeletal pain.
Methods: The 7 week SMP was co-delivered by lay and health professional tutors. Patients completed
self-reported outcome measures at pre-course and 6 months follow-up.
Results: 486 patients completed (attended 5 sessions) the SMP and returned pre-course and 6 months
follow up data. Patients reported significant improvements in patient activation (ES 0.65, p < 0.001),
with 53.9% of all patients reporting a meaningful 4 point improvement. Health-related quality of life
(ES 0.06, p = 0.04), and health status (ES 0.33, p < 0.001) were also significantly improved. Patients’
anxiety (ES 0.37, p < 0.001) and depression (ES 0.31, p < 0.001) significantly improved. Patients also
reported significant improvements in their self-management skills (p values from p < 0.001 to
p = 0.028).
Conclusion: Attending the SMP led to improvements in a range of outcomes. Improvement in patient
activation is important, as activated patients are more likely to perform self-care activities.
Practice implications: Co-delivered SMPs provide meaningful improvements in activation for >50% of
those who complete and are a useful addition to self-management support provision.
 2014 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-
ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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The burden of noncommunicable diseases (NCDs), which are
also known as long-term conditions (LTCs), is rapidly increasing
worldwide [1] and it is predicted that by 2020 LTCs will account for
almost three-quarters of all deaths worldwide [2]. By 2025 the
number of people in England with at least one LTC will rise by 3
million to 18 million [3]. Government policy places emphasis on
self-management as a means of improving the management of
LTCs, and supporting patient participation in healthcare is seen as a
key mechanism to improve self-management [4,5]. National
Health Service quality improvement programs position patient
centeredness and patient involvement, as well as self-manage-
ment support for LTCs, at the heart of government initiatives* Corresponding author at: Applied Research Centre in Health and Lifestyle
Interventions, WF 109, Faculty of Health and Life Sciences, Coventry University,
Priory Street, Coventry CV1 5FB, UK.
Tel.: +44 02476887459; fax: +44 02476795987.
E-mail address: a.turner@coventry.ac.uk (A. Turner).
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nd/3.0/).[6]. Many patients with a LTC want to participate more in their
health care and would feel more confident with the support and
encouragement from their health care provider. However, the
majority of patients feel this support and encouragement is
currently lacking [7]. Nearly two-thirds of patients also believe
that their confidence to self-care would increase with the provision
of support from others who had similar health concerns [7]. The
push towards greater involvement of people in their own care
reflects the pressure on the NHS from the rising number of people
with LTCs.
In the UK, self-management programs (SMPs) delivered by
patients (lay-led), such as the Expert Patient Program (EPP), have
emerged. A systematic review and meta-analysis involving nearly
7500 LTC patients who attended lay-led and lay and health
professional co-delivered SMPs reported small improvements in
self-efficacy, depression, pain, disability, fatigue, self-rated health,
aerobic exercise and cognitive symptom management [8]. The
largest UK randomized controlled trial of the EPP showed
improvements in energy, self-efficacy and other psychosocial
outcomes and that it was cost-effective [9]. Despite these benefits,
primary and secondary care services were reluctant to engage witharticle under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
Table 1
SMP course content.
Session
number
Session activities
Session 1 Welcome, introduction and ground rules
What is self-management? How is it different from before?
Balancing life with a long term condition
What is . . . (diabetes, COPD, depression, pain). . .?
Exercise. Why do it?
Goal setting and planning for action
Session 2 Welcome and reflections from last session
Follow up and feedback
Boom and bust-over-activity/under-activity
Breathing
Condition specific activitya
Symptom scanning
Thinking about our beliefs
Counting blessings/saying thanks
Goal setting and planning for action
Session 3 Welcome and reflections from last session
Follow up and feedback
Positive self talk
Being more active
Condition specific activitya
Muscle relaxation
Pacing
Physical activity
Sleep
Goal setting and planning for action
Session 4 Welcome and reflections from last session
Follow up and feedback
Communication with family, friends and colleagues
Introduction to mindfulness
Managing our medication
Condition specific activitya
Managing our fatigue
Celebrating success so far
Goal setting and planning for action
Session 5 Welcome and reflections from last session
Follow up and feedback
Condition specific activitya
Managing the emotional impact
Using distraction
Pursed lip breathing
Recognising setbacks
Physical activity
Solving problems
Goal setting and planning for action
Session 6 Welcome and reflections from last session
Follow up and feedback
Condition specific activitya
Managing setbacks
Follow up and sharing our success with clinician
Setting the agenda
Making the most of our consultations with health professionals
Physical activity/relaxation
What have we covered? Should we revisit anything?
Goal setting and planning for action
a Condition specific activities were different for all of the four long-term
conditions.
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inclusion of health care practitioners to provide condition specific
information would be a useful addition to the valuable social
modelling provided by lay tutors [11].
The Health Foundation, which is an independent charity
working to continuously improve the quality of healthcare in
the UK, sought to develop a national quality improvement
demonstration program. The approach, called Co-Creating Health
(CCH), was influenced by the policy context around self-manage-
ment in the UK and on reviews of research and practice, and
emerging quality improvement programs, especially those using
some or all of Wagner’s chronic care model (CCM) [12]. According
to the CCM, one of the main objectives for health services is to
support self-management, which needs to be embedded in a
system that includes knowledgeable and confident patients,
prepared clinicians and a responsive and flexible administrative
structure [13]. Hence, CCH provides support at the patient,
clinician and service level.
In this paper we describe the development and evaluation of an
SMP for patients with a LTC. CCH Clinician self-management
support practices are reported elsewhere [14,15]. The primary aim
of this evaluation was to see whether the SMP improved patient
activation, which refers to the extent that patients have the
knowledge, skills, and confidence, to use self-management support
skills in their lives [16]. The evaluation also looked at whether the
SMP improved health related quality of life, health status, mental
health and self-management skills.
2. Methods
2.1. Patients and procedure
Each of the CCH demonstration sites spanned primary and
secondary care. CCH focused on four LTCs: chronic obstructive
pulmonary disease (COPD), depression, diabetes, and musculo-
skeletal pain across eight NHS sites, with two sites each focusing
on the same condition. LTC patients seen in primary or
secondary care settings were informed by their healthcare
provider about the SMP. LTC patients’ inclusion criteria were to
be over 18 years of age, have one of the four LTCs of interest
(COPD, depression, diabetes and pain) and be physically able to
attend a seven session group-based SMP. The SMP was delivered
for groups of patients with the same LTC, so that patients
recruited from COPD sites attended a COPD specific SMP, and the
same applied for the other three conditions. Patients’ comorbid
status was not a factor for recruitment to the SMP. Data were
collected from patients who attended SMPs between 2007 and
2011. The study protocol was approved by the Brighton and
Hove City Teaching PCT Multi Center Research Ethics Committee
07/H1107/143.
2.1.1. Procedure
Patients who wished to attend the SMP registered their interest
via a dedicated recruitment telephone helpline. The contact details
of patients who consented to take part in the evaluation were
passed to the evaluation team. Pre-course questionnaires (Time 1)
were mailed out to patients by the evaluation team. Reminder and
follow-up calls prior to attendance were made to improve response
rates. In keeping with the real world setting of the evaluation, LTC
patients who chose not to participate in the evaluation were not
excluded from the SMP. All patients were mailed out 6 month
follow-up questionnaires (Time 2). Two reminder follow-up
contacts were made. During the second attempt patients were
offered the option to verbally complete the primary outcome
measure, the Patient Activation Measure.2.2. Intervention
The Health Foundation commissioned the Expert Patient
Program Community Interest Company to develop the SMP. The
Co-Creating Health SMPs are four condition specific programs,
which are supplemented by generic core modules and activities
(e.g. goal setting, problem solving, and relaxation). Table 1
provides a description of the course content.
The condition specific content was developed by the demon-
stration sites, with input from clinicians and patients who were
1 Missing data for 47 patients and these were deemed to have attended 4
sessions 12 patient activation over time. ITT analysis produced similar results.
53.9% of patients showed a meaningful improvement (i.e. 4 points) in patient
activation scores.
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SMP was a 7 week, 3 h group-based SMP co-delivered by a health
professional tutor (e.g. psychologist, clinical nurse specialist,
physiotherapist) who worked locally in the relevant pathway of
care, and a patient (lay) tutor who had experience of these services.
The SMP is grounded in social learning theory [17] and includes
four efficacy enhancing strategies: skills mastery, social modelling,
social persuasion and reinterpretation of symptoms. Tutors attend
4 days of classroom based training, which involves brief
motivational interviewing and behavior change skills, group
facilitation skills and delivery practice of the SMP activities.
Delivery is guided by a tutor’s manual to ensure consistency of
delivery and content. Tutors are trained and accredited to a
rigorous set of quality standards with training and course delivery
focusing on adherence to the timing, sequence and coverage of
activities as set out in the manual to ensure fidelity. All activities
can be either delivered by the health professional or lay tutor.
Tutors decide in advance which activities they would like to lead
on. Our observations of the SMP (reported elsewhere) using
process evaluation using a Self Determination Theory [18] showed
co-delivery was a successful model and that lay and health
professional tutors had similar motivational styles to promote
participant engagement and learning [19].
2.3. Outcome measures
Demographic information such as age, gender, employment
status and co-morbidity, was collected at baseline only. A range of
outcome measures was selected to best capture the important
outcomes of the SMP.
2.3.1. Patient Activation Measure (PAM)
The PAM assesses patient activation [16], which is conceptually
similar to self-efficacy [17]. It comprises 13 items that assess
patient knowledge, skill and confidence for self-management. The
PAM has a theoretical range from 0 to 100. Higher scores indicate
greater activation. An improvement in 4 points on the PAM scale is
considered meaningful as this is the level of increase which is
associated with performing a range of self-management behaviors
[20–22].
2.3.2. EuroQol
The EuroQol index (EQ 5D index) and the EuroQol Visual
Analogue Scale (EQ VAS) are widely used measures of health status
and health-related quality of life respectively [23]. The EQ-5D
index assesses patients’ health state across five dimensions (self-
care, mobility, anxiety/depression, usual activities and pain/
discomfort) that are weighted to provide a utility value based
on a population tariff, scores range from 0 (death) to 1 (perfect
health). The EQ VAS is a vertical rating scale health scored between
0 (worst imaginable health) and 100 (best imaginable health).
2.3.3. Hospital Anxiety and Depression Scale (HADS)
The Hospital Anxiety and Depression Scale (HADS) [24]
provides separate scores for anxiety and depression ranging from
0 to 21, with higher scores indicating greater anxiety and greater
depression. Scores 11 are considered to indicate probable clinical
anxiety and depression (‘‘cases’’).
2.3.4. Health Education Impact Questionnaire (heiQ)
Self-management ability was measured using the heiQ [25].
Patients are asked to rate items on a 4 point likert scale ranging
from ‘‘strongly disagree’’ (1) to ‘‘strongly agree’’ (4). Higher scores
represent higher levels of self-management abilities. The eight
scales are: positive and active engagement in life; health directed
behavior; skill and acquisition technique; constructive attitudesand approaches; self-monitoring and insight; health services
navigation; social integration and support; emotional well-being.
Condition specific measures for COPD, depression, diabetes and
pain were also collected at baseline and 6 months follow-up.
Interviews were also conducted with patients and tutors across all
4 conditions. These data are reported separately in other
publications [26].
2.4. Analysis
All data analyses were conducted using IBM SPSS Statistics
20. The main analysis involved only those patients who attended
5 SMP sessions (defined as course completers) and returned
6 month follow-up questionnaires. The level of statistical
significance was set at p = 0.05. An intention to treat (ITT) analysis
was also performed on all patients, irrespective of the number of
sessions attended to ensure that the effectiveness of the program
has not been overestimated. Missing 6 month follow-up data (T2)
were replaced with baseline data, last observation carried
forward.
Changes in the mean values of the patient outcomes were
compared over time using paired t tests and General Linear Model
for repeated measures. The outcome variables were normally
distributed. For the main analysis only important prognostic
factors such as age, gender, long-term condition, co-morbidity,
number of sessions attended and socioeconomic factors (educa-
tion, employment status) were adjusted for using analysis of
covariance. Effect sizes (Cohen’s d) [27] were calculated using the
following calculation: the mean score at 6 months minus the mean
score at baseline divided by the standard deviation at baseline.
Recommended boundaries [27] were used to determine small
(0.2), moderate (0.5) and large effect sizes (0.8). The heiQ scale
developers recommend a distribution-based cut-off of ES = 0.5 as a
standardised cut-off [28]. Based on this cut-off, three categories of
change were defined: ‘substantial improvement’ (ES 0.5),
‘minimal/no change’ (0.50 < ES < 0.50), ‘substantial decline’
(ES 0.5). We also looked the proportion of patients whose
PAM scores improved by 4 points. Changes in ‘‘caseness’’ for
anxiety and depression between baseline and 6 months follow-up
were tested using McNemar’s test.
3. Results
3.1. Demographic variables
In total, 1850 patients contacted the EPPCiC recruitment
helpline, and of these, 563 (30%) patients did not register to
attend the SMP. 1170 patients completed baseline questionnaires,
and 568 patients (49%) completed 6 months follow-up ques-
tionnaires. Patient characteristics are summarised in Table 1.
Patients were on average 56.3 years of age, predominantly white
ethnicity and female. A quarter were in full or part time
employment. Nearly two-thirds had a co-morbid condition.
Musculoskeletal pain patients were the largest patient group
(31%).
SMP completion rates (5 SMP sessions) averaged 69% (805/
1170)1 across all 4 LTCs. Where we could establish direct pairing of
data from patients who completed baseline and 6 month surveys
and who attended 5 SMP sessions for the main analysis, there
were 486 matched PAM scores. Response rates were lower for
other outcome measures as we only collected PAM data at
A. Turner et al. / Patient Education and Counseling 98 (2015) 213–2192166 months follow-up among those patients who were subject to
repeat follow-up attempts.
Patients who completed the SMP tended to be significantly
older (mean age 59 years compared to 55 years), significantly less
anxious (mean 10.0 compared to 10.9) and significantly less
depressed (mean 8.0 compared to 8.6) than those who dropped out
of the SMP (attended 0–4 sessions). These findings are confounded
with the lower completion rates among patients with depression
(63% compared to CCH average of 69%), who also tended to be
younger and more anxious than patients with other LTC diagnoses.
There were no other demographic differences, between patients
who completed the SMP and those patients who did not complete
the SMP on variables of gender, ethnicity, house ownership, living
arrangements, education, employment, co-morbidity, patient
activation, health status or quality of life (Table 2).
3.2. Outcomes
3.2.1. Patient activation
Patient activation significantly improved 6 months after
completing the SMP (p < 0.001, effect size = 0.65) (Table 3). None
of the prognostic and demographic factors predicted patient
activation over time. ITT analysis produced similar results. 53.9% of
patients showed a meaningful improvement (i.e. 4 points) in
patient activation scores.
3.2.2. Health status and health-related quality of life
Patients’ health status as measured by EQ-VAS significantly
improved 6 months after completing the SMP (p < 0.001, ES = 0.33)
(Table 2). None of the prognostic and demographic factors
predicted health status over time. Intention to Treat (ITT) analysis
produced similar results.
Patients’ health-related quality of life significantly improved 6
months after completing the SMP (p = 0.042, ES = 0.06) (Table 2).
Condition was a predictor of change in quality of life over time
(p < 0.045). Health-related quality of life was lower at baseline for
depression and patients with musculoskeletal pain in comparison
to that of patients with COPD and patients with diabetes.Table 2
Patients’ characteristics enrolling on the SMP and who returned
a baseline questionnaire (N = 1170).
Characteristics Mean (SD)
Age 56.3 (14.6)
Characteristics %
Gender
Male 36
Female 64
Ethnic origin
White 81
Accommodation
Owner occupier 61
Living arrangements
Live alone 32
Age left education
Below 16 years 31
16–18 years 41
19 28
Employment
FT/PT 25
Other (retired, housewife/husband, student) 75
LTC
COPD 18
Depression 27
Diabetes 24
Pain 31
Co-morbidity 65Furthermore, improvements at 6 months follow-up were greater
in these patients. ITT analysis produced similar results.
3.2.3. Psychological distress
Patients’ anxiety and depression decreased significantly 6
months after completing the SMP (both p < 0.001, ES = 0.37 and
0.31 respectively) (Table 2). Condition was apredictor of change in
anxiety over time (p < 0.001). Patients with depression and
musculoskeletal pain had higher levels of anxiety at baseline
compared to patients with COPD and patients with diabetes.
Furthermore, their improvement was greater at 6 months follow-
up. Condition was also apredictor of changes in depression over
time (p < 0.001). Patients with depression and patients with pain
had higher levels of anxiety at baseline compared to patients with
COPD and patients with diabetes and their improvement was
greater at 6 months follow-up. ITT analysis produced similar
results. At baseline 39.8% of patients were clinically anxious
(caseness (11)) and at 6 months follow-up this had significantly
reduced to 29.7% (p < 0.001). Compared with baseline, 17% moved
from clinical to non-clinical anxiety, 7% moved from non-clinical to
clinical and 76% stayed the same. At baseline 25.6% of patients
were clinically depressed (caseness (11)) and at 6 months follow-
up this had significantly reduced to 16.0% (p < 0.001). Compared
with baseline, 15% moved from clinical to non-clinical depression,
6% moved from non-clinical to clinical and 79% stayed the same.
3.2.4. Self-management skills
Patients’ self-management skills in all eight heiQ domains
significantly improved 6 months after attending the SMP: Health
Directed Behavior: (p = 0.028); Positive and Active Engagement;
Emotional Well-Being; Self-Monitoring and Insight; Constructive
Attitude Shift; Skills and Technique Acquisition (all p < 0.001);
Social Integration and support; p = 0.002, and Health Service
Navigation (p = 0.012). Effect sizes ranged from 0.67 for Skills and
Technique Acquisition to 0.17 for Health Service Navigation
(Table 2). Condition was a predictor of change in three of the
domains: patients with depression reported a statistically signifi-
cant improvement over time on Positive and Active Engagement,
Constructive Attitude Shift (both p < 0.001) and Social Integration
and Support (p < 0.002). Patients with diabetes also reported an
improvement in this domain (p = 0.03). ITT analysis produced
similar results. About a quarter of patients showed substantial
improvements in self-management skills, the exceptions being
skill and technique acquisition (35.4%) improvement and health
service navigation (18.3%) (Table 4).
4. Discussion and conclusion
4.1. Discussion
The WHO has called upon all countries to provide interventions,
including self-care interventions, to address the worldwide LTC
epidemic [29]. This study, which describes an evaluation of a
group-based SMP carried out in a real world health care setting
showed that, it has the potential to improve patient activation,
quality of life, psychological distress and self-management skills.
We do not know the total number of LTC patients who were
approached by health care staff at each site to register with the
SMP recruitment helpline. We do know that 30% of patients who
contacted the recruitment helpline did not subsequently attend
the SMP.
The SMP completion rate, (5 sessions) among those who
completed the pre course questionnaire, of 69% compares
favourably against those of two other UK self-management
studies, which reported completion rates of 60% [9] and 51%
[30]. Factors affecting uptake, such as being referred by a known
Table 3
Baseline and 6 months follow-up scores (mean and (SD)).
Outcome variable Baseline
mean (SD)
6 months
mean (SD)
Effect size of
change (per protocol)
p value main
analysis (N = 486a)
p value intention
to treat (N = 1170)
Patient Activation Measure (0–100 = better) 52.2 (12.4) 60.2 (15.8) 0.65 <0.001 <0.001
EQ-index Health Status (0–1 = better) 0.5 (0.3) 0.6 (0.3) 0.33 <0.001 <0.001
EQ-VAS HRQL (0–100 = better) 55.9 (20.8) 57.2 (21.4) 0.06 0.042 0.006
HADS (0–21 = better)
Anxiety 10.0 (5.1) 8.1 (4.7) 0.37 <0.001 <0.001
Depression 7.9 (4.5) 6.5 (4.1) 0.31 <0.001 <0.001
heiQ (1–4 = better)
Health Directed Behavior 2.7 (0.7) 2.9 (0.7) 0.29 0.028 0.072
Positive and Active Engagement 2.6 (0.7) 2.8 (0.7) 0.29 <0.001 <0.001
Emotional Well-being 2.2 (0.7) 2.4 (0.7) 0.29 <0.001 <0.001
Self-Monitoring and Insight 2.9 (0.5) 3.1 (0.5) 0.40 <0.001 <0.001
Constructive Attitude Shift 2.7 (0.7) 2.9 (0.6) 0.29 <0.001 <0.001
Skills and Technique Acquisition 2.6 (0.6) 3.0 (0.5) 0.67 <0.001 <0.001
Social Integration and Support 2.6 (0.7) 2.8 (0.6) 0.29 0.002 <0.001
Health Service Navigation 2.9 (0.6) 3.0 (0.6) 0.17 0.012 0.028
a For primary outcome measure (PAM). Sample size was smaller for other outcome measures.
Table 4
Distribution of the proportion of patients with ‘‘substantial improvement’’, ‘‘minimal/no improvement’’, or ‘‘substantial decline’’.
heiQ subscales Substantial improvement (ES  0.5) Minimal/no change (0.50 < ES < 0.50) Substantial decline (ES  0.5)
Health Directed Behavior (N = 345) 22.9% 60.9% 16.2%
Positive and Active Engagement (N = 344) 25.3% 61.9% 12.8%
Emotional Well-being (N = 346) 26.0% 61.3% 12.7%
Self-monitoring and Insight (N = 346) 22.5% 69.7% 7.8%
Constructive Attitude Shift (N = 339) 24.5% 66.1% 9.4%
Skills and Technique Acquisition (N = 342) 35.4% 58.8% 5.8%
Social Integration and Support (N = 341) 24.0% 61.6% 14.4%
Health Service Navigation (N = 338) 18.3% 69.8% 11.8%
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the high completion rates achieved. We have reported elsewhere
that the co-delivery model was well received by patients [19].
Generally, more men, ethnic minorities, people who lived alone,
who had no educational qualifications and did not own their own
homes, attended the SMP when compared to other UK self-
management programs [9]. This suggests that the SMP was
relatively successful at recruiting patients who traditionally do not
attend self-management programs.
Irrespective of condition, patients who completed the SMP were
more activated. The 8.0 point mean improvement in the PAM score
compares to a 4.7 mean improvement reported by patients
attending a similar self-management program in the United States
[31]. Over half (53.9%) of patients reported a meaningful (4 point)
improvement in activation. Improved activation on the PAM is
important because other research has shown that activated
patients are more likely to participate in collaborative decision-
making with their clinicians, report improved health-related
behaviors and clinical outcomes and adhere to physical therapy
[32,33].
Patients with depression and patients with musculoskeletal
pain enjoyed better health status after attending the SMP. Only
patients with depression enjoyed a significantly improved health
related quality of life as measured by the generic EQ VAS. Two
other self-management studies [34,35] similarly found no
improvement using the EQ VAS among patients with arthritis
and patients with COPD respectively. A recent meta-analysis of
Stanford University’s arthritis self-management programs (ASMP)
and generic chronic disease self-management course (CDSMC)
suggested that improvements in quality of life might take longer
(i.e. >12 months) to emerge compared to other outcomes such as
self-efficacy [36]. Further, it has been suggested that some generic
measures may not be sensitive enough to adequately capturequality of life improvements after attending self-management
programs [37].
Patients with depression and patients with musculoskeletal
pain, who were more anxious and depressed at baseline compared
to patients with COPD and patients with diabetes, reported
significant reductions in these outcomes at follow-up. More
patients, approximately 10%, were no longer clinically anxious
or depressed. NICE recommends a collaborative care approach for
LTC patients with co-morbid mental health problems in primary
care which includes patient education and self-management
support [38].
The finding that patients across all 4 conditions were
significantly more often using self-management skills and
techniques, as measured by the heiQ subscale skills and technique
acquisition, is important given that the primary aim of the SMP is
to enhance patients’ ability and capacity to self-manage their
condition. Patients with depression showed improvements in 7 out
of 8 domains, and patients with diabetes showed improvements in
6 out of 8 domains. These patients were using more self-
management techniques compared to patients with COPD and
patients with musculoskeletal pain who showed improvements in
2 out of 8 domains. Where improvement occurred most of the
effect sizes were small. It has been argued that modest effects have
public health significance when experienced on a population level
[34]. Patients with depression had lower self-management scores
at baseline compared to patients with the other three conditions
and so had more opportunity to improve. Recent evaluations of the
Stanford University, lay-led, Chronic Disease Self-Management
Programme has shown improvements in depression and other
health outcomes for people living with serious mental health
conditions [39,40]. The finding that self-management programs
can benefit patients with depression and other serious mental
health conditions is noteworthy. Mental ill health accounts for 13%
A. Turner et al. / Patient Education and Counseling 98 (2015) 213–219218of all lost years of healthy life globally, rising to 23% in high-income
countries [41,42].
For most of the heiQ domains approximately a quarter of
patients made substantial improvements, the exception being in
skill and technique acquisition where more than a third reported
substantial improvement. This is lower than reported by LTC
patients in Australia, which showed that one third of patients
showed substantial improvement in the majority of the heiQ
domains [28]. The difference could be explained by the fact that
Australian data were collected at post-course whereas our data
were collected at 6 months follow-up and there may be some
attenuation of effects.
4.1.1. Limitations
The questionnaire return rate at 6 months is lower than we have
achieved in other self-management evaluations (e.g. 83% [34] and
80% [43]). We are unsure as to the exact reasons why this lower
rate occurred and can only speculate that the pragmatic, real world
design of the study, where greater emphasis and importance were
afforded to implementation and delivery of the interventions
rather than to the recruitment and retention of patients in the
evaluation, could have impacted on this. The main analyses on SMP
completers (attended 5 sessions) present the most favourable
estimation of outcomes as it focuses only on those patients who
received a high dose of the SMP and completed baseline and
6 month follow-up questionnaires. ITT analysis showed similar
improvements at 6 month follow-up, but were of a smaller
magnitude.
The biggest limitation is the lack of a control group, which
means that there are alternative explanations for the improve-
ments reported by patients completing the SMP. However, the size
of improvements is generally consistent with randomized
controlled trials of SMPs which are similar in process and content
[9,28,34,43,44]. Future research designs should involve a random-
ized controlled trial of the SMP using alternative self-management
interventions as a comparison group. Clinical outcome (e.g. HBA1c
for diabetes and FEV1 for COPD) and health care utilisation data
should also be collected in any future studies.
4.2. Conclusions
Over half of all patients made meaningful improvements in
patient activation after completing the SMP and about 10% were no
longer classified as ‘‘cases’’ for anxiety and depression. A quarter of
patients reported substantial improvements in self-management
skills. Targeting and recruiting patients, especially patients with
depression, with greater needs will deliver the greatest benefits.
4.3. Practice implications
Over twenty countries provide a version of the Stanford
University SMP, which is delivered by lay tutors [45] and continues
to be positively evaluated [46]. This evaluation showed that a co-
delivered (lay and professional tutor) SMPs can produce meaning-
ful improvements in important outcomes such as activation, self-
management skills and psychological distress for LTC patients. The
SMP can be embedded in existing pathways of care at relatively
low cost and has a potential to generate significant health care
savings if improvements in activation are translated into lower use
of services.
Consent
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